Characteristic | |
---|---|
Age (years), median (range) | 51 (18, 76) |
BMI (kg/m2), median (range) | 22.1 (15.8, 34.8) |
Body surface area (m2), median (range) | 1.42 (1.21, 1.71) |
ECOG performance status (%) | |
 Normal activity | 56 (90.3) |
 Restricted activity | 6 (9.7) |
Histology (%) | |
 High grade serous adenocarcinoma | 46 (74.2) |
 Mucinous adenocarcinoma | 3 (4.8) |
 High grade endometrioid adenocarcinoma | 3 (4.8) |
 Clear cell carcinoma | 5 (8.1) |
 Malignant mixed mullerian tumor | 5 (8.1) |
FIGO stage (%) | |
 IIIC | 43 (69.4) |
 IV | 19 (30.7) |
Surgical treatment (%) | |
 Primary debulking surgery | 44 (71.0) |
 Interval debulking surgery | 18 (29.0) |
Gross residual disease (%) | |
 Yes | 43 (69.4) |
 No | 19 (30.7) |
Surgical complexity (%) | |
 Low | 5 (8.1) |
 Moderate | 40 (64.5) |
 High | 17 (27.4) |
ICU stay (%) | |
 Yes | 2 (3.2) |
 No | 60 (96.8) |
Serum creatinine (umol/L), median (range) | |
 Prior to HIPEC | 63.5 (49, 159) |
 Following HIPEC | 62.0 (48, 149) |
Serum albumin (g/l), median (range) | |
 Prior to HIPEC | 25 (15, 36) |
 Following HIPEC | 22 (15, 30) |